Kehamilan Post-Term

01Pathophysiology

Post-term pregnancy is defined as a pregnancy that has reached or exceeded 42 weeks and 0 days (≥294 days) from the first day of the last menstrual period. The term "late-term" refers to pregnancies between 41 weeks 0 days and 41 weeks 6 days, a distinction that matters because risk begins to climb during this window.

Normal labor initiation depends on a coordinated cascade: the fetal hypothalamic-pituitary-adrenal (HPA) axis produces cortisol, which stimulates placental conversion of progesterone to estrogen. Rising estrogen promotes prostaglandin synthesis and oxytocin receptor expression in the myometrium. When this signaling fails or is delayed, the pregnancy continues beyond term. In fetal anencephaly or adrenal hypoplasia, the absence of adequate fetal cortisol output directly disrupts this pathway. In placental sulfatase deficiency, estrogen precursors cannot be converted, and the progesterone-to-estrogen shift never occurs.

As the pregnancy extends beyond 42 weeks, the placenta undergoes progressive aging: calcification increases, villous surface area shrinks, and perfusion declines. This leads to uteroplacental insufficiency, which is the central mechanism linking post-term pregnancy to its complications. Reduced placental function causes decreased amniotic fluid production (oligohydramnios), impaired gas exchange (chronic fetal hypoxia), and nutrient restriction.

Oligohydramnios develops because fetal renal perfusion drops in response to redistribution of blood flow to vital organs (brain, heart, adrenals), reducing urine output. Less amniotic fluid means the umbilical cord is more vulnerable to compression, worsening intermittent hypoxia. This hypoxic environment triggers the fetal vagal reflex, causing meconium passage into the diminished amniotic fluid. Thick meconium in reduced fluid volume raises the risk of meconium aspiration syndrome (MAS) at delivery.

Fetal growth in post-term pregnancy follows two divergent paths. In about 20% of cases, the fetus continues to grow, resulting in fetal macrosomia (>4000 g), which increases the risk of shoulder dystocia, birth trauma, and cesarean delivery. In the remaining cases, placental insufficiency leads to dysmaturity syndrome (postmaturity syndrome): the fetus stops gaining weight, consumes subcutaneous fat stores, and is born with the classic wasted, wrinkled appearance with peeling skin and long nails.

The most feared complication is stillbirth. The risk of intrauterine fetal death doubles from 1 per 3,000 at 37 weeks to approximately 3 per 3,000 at 42 weeks and continues to rise with each additional week.

02Classification and Clinical Manifestation

Gestational Age Classification

Clifford Classification

Maternal vs. Fetal Complications

03Diagnostic Workup

The single most important question in any vignette about post-term pregnancy is: "Are the dates accurate?" The most common reason a pregnancy appears post-term is inaccurate dating based on an unreliable last menstrual period. A first-trimester ultrasound using crown-rump length is the gold standard for dating, accurate to within 5 to 7 days. If a patient presents at "43 weeks by LMP" but had no early ultrasound, the true gestational age may be significantly different. On an exam, look for the stem to mention whether a dating ultrasound was performed. If it was not, the best initial step is often to obtain or review ultrasound dating before proceeding with intervention.

Once the gestational age is confirmed and the pregnancy is truly at or beyond 41 weeks, the next step is antepartum fetal surveillance. The most commonly used approach is the modified biophysical profile (modified BPP), which combines a non-stress test with amniotic fluid index measurement. This is performed twice weekly starting at 41 weeks.

The non-stress test evaluates the fetal heart rate pattern. A reactive NST (two or more accelerations of ≥15 beats per minute lasting ≥15 seconds within a 20-minute window) is reassuring. A non-reactive NST warrants further evaluation with a full BPP or contraction stress test.

The amniotic fluid index is the sum of the deepest vertical pockets in four uterine quadrants. An AFI of ≤5 cm (or a single deepest vertical pocket of ≤2 cm) indicates oligohydramnios, which in the post-term setting reflects declining placental function and reduced fetal renal perfusion. Oligohydramnios in a post-term pregnancy is an indication for delivery regardless of other findings.

The full biophysical profile scores five parameters, each worth 0 or 2 points (maximum score of 10): fetal breathing movements, gross body movements, fetal tone, amniotic fluid volume, and NST. A score of 8 to 10 (with normal fluid) is reassuring. A score of 6 is equivocal and requires repeat testing or delivery depending on gestational age. A score of 4 or below warrants delivery.

04Management and Treatment

Step 1: Confirm gestational age. Review the earliest available ultrasound. If first-trimester dating was performed and confirms ≥41 weeks, proceed. If no early ultrasound exists, clinical judgment is required, but most guidelines recommend managing as if the dates are correct rather than waiting.

Step 2: Assess cervical readiness. Perform a digital cervical exam and calculate the Bishop score, which evaluates dilation, effacement, station, consistency, and position. A Bishop score of 6 or greater predicts successful induction and allows direct oxytocin administration. A score below 6 requires cervical ripening before oxytocin.

Step 3: Cervical ripening (if needed). The two main options are pharmacologic and mechanical.

For pharmacologic ripening, misoprostol (prostaglandin E1) at 25 mcg placed intravaginally every 3 to 6 hours is effective and inexpensive. Dinoprostone (prostaglandin E2) is available as a vaginal insert (10 mg, slow-release over 12 hours) or intracervical gel (0.5 mg every 6 hours, maximum 3 doses). Prostaglandins are absolutely contraindicated in patients with a prior cesarean scar or any history of uterine surgery due to the elevated risk of uterine rupture.

For mechanical ripening, a transcervical Foley catheter (inflated with 30 to 80 mL of saline) provides gentle dilation and can be used safely in patients with prior uterine scars when prostaglandins are contraindicated.

Step 4: Induction with oxytocin. Once the cervix is favorable, oxytocin is administered as a continuous IV infusion. Low-dose protocols begin at 1 to 2 mU/min with incremental increases every 15 to 30 minutes. The goal is achieving an adequate contraction pattern (3 to 5 contractions per 10 minutes) while monitoring for tachysystole.

Step 5: Intrapartum monitoring. Continuous electronic fetal monitoring is required during induction. Watch for late decelerations (a sign of uteroplacental insufficiency) and variable decelerations (suggesting cord compression, particularly with oligohydramnios). If meconium-stained fluid is noted at amniotomy, alert the neonatal team and maintain continuous monitoring.

Step 6: Cesarean delivery. Indicated for failed induction (inability to achieve active labor despite adequate oxytocin and time) or non-reassuring fetal heart rate tracings that do not respond to intrauterine resuscitation (maternal repositioning, IV fluid bolus, discontinuation of oxytocin, or amnioinfusion).

Key Contraindications to Know

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common trap in questions about post-term pregnancy involves dating. A vignette will present a woman at "43 weeks by her last menstrual period" who had no early ultrasound, irregular cycles, or uncertain dates. The temptation is to jump straight to induction of labor, but the best initial step is to confirm gestational age with the most reliable data available. If no first-trimester ultrasound exists, the question is testing whether you understand that the diagnosis of post-term pregnancy itself may be wrong before you intervene.

The second common trap is the oligohydramnios trigger. When a vignette describes a post-term patient with an AFI of 4 cm or a deepest pocket of 1.5 cm, the answer is delivery, not continued surveillance. Students who choose "repeat BPP in 24 hours" lose the point because oligohydramnios in a post-term pregnancy is an independent indication for delivery.

A third pitfall involves prostaglandin use in patients with a prior cesarean. If the vignette mentions a previous low-transverse cesarean scar and an unfavorable cervix at 41 weeks, the answer is mechanical ripening with a Foley catheter, not misoprostol. Selecting misoprostol in this scenario is a high-yield wrong answer designed to catch students who do not recognize the contraindication.

Finally, remember the fetal versus neonatal distinction. A question describing a post-term fetus with non-reassuring heart tracings is testing antepartum management (delivery). A question describing a newborn with respiratory distress, meconium below the cords, and a chest X-ray showing patchy infiltrates is testing meconium aspiration syndrome, a neonatal condition. The management shifts from obstetric intervention to neonatal resuscitation and respiratory support. Recognizing which phase of care the vignette is testing is the core competency.

The overarching skill being assessed in post-term pregnancy questions is the ability to sequence clinical decisions correctly: confirm dates first, then initiate surveillance, then decide on delivery timing and method based on cervical status and fetal well-being. Every wrong answer on these questions comes from skipping a step or acting on incomplete information.